IRIS
PORTA, CAMILLO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.496
AS - Asia 4.382
EU - Europa 2.922
SA - Sud America 485
AF - Africa 87
OC - Oceania 9
Continente sconosciuto - Info sul continente non disponibili 4
Totale 13.385
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.369
CN - Cina 2.347
IE - Irlanda 1.167
SG - Singapore 1.045
HK - Hong Kong 564
RU - Federazione Russa 504
BR - Brasile 388
FI - Finlandia 339
DE - Germania 277
VN - Vietnam 159
UA - Ucraina 117
IT - Italia 106
SE - Svezia 99
GB - Regno Unito 86
CA - Canada 70
IN - India 66
FR - Francia 43
PL - Polonia 40
MX - Messico 39
JP - Giappone 36
AR - Argentina 34
ZA - Sudafrica 32
ES - Italia 28
BD - Bangladesh 27
NL - Olanda 27
TR - Turchia 21
IQ - Iraq 16
AT - Austria 15
EC - Ecuador 15
LT - Lituania 14
CZ - Repubblica Ceca 13
BE - Belgio 11
MU - Mauritius 11
SA - Arabia Saudita 10
CO - Colombia 9
ID - Indonesia 9
IL - Israele 9
PY - Paraguay 9
VE - Venezuela 9
AZ - Azerbaigian 8
MA - Marocco 8
CL - Cile 7
KE - Kenya 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
PE - Perù 6
PH - Filippine 6
UZ - Uzbekistan 6
AU - Australia 5
IR - Iran 5
LV - Lettonia 5
PK - Pakistan 5
BG - Bulgaria 4
DZ - Algeria 4
EG - Egitto 4
KZ - Kazakistan 4
MY - Malesia 4
UY - Uruguay 4
BO - Bolivia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
GA - Gabon 3
GR - Grecia 3
JO - Giordania 3
MN - Mongolia 3
PA - Panama 3
PS - Palestinian Territory 3
PT - Portogallo 3
SK - Slovacchia (Repubblica Slovacca) 3
SN - Senegal 3
AL - Albania 2
AM - Armenia 2
BB - Barbados 2
CR - Costa Rica 2
DM - Dominica 2
EU - Europa 2
HN - Honduras 2
HU - Ungheria 2
IS - Islanda 2
KG - Kirghizistan 2
KH - Cambogia 2
LB - Libano 2
MD - Moldavia 2
NZ - Nuova Zelanda 2
TM - Turkmenistan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BS - Bahamas 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CM - Camerun 1
CY - Cipro 1
DJ - Gibuti 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
GY - Guiana 1
HR - Croazia 1
IM - Isola di Man 1
Totale 13.367
Salva come PNG Salva come JPEG
Città #
Dublin 1.167
Chandler 870
Beijing 632
Hong Kong 563
Dallas 518
Ashburn 501
Singapore 409
Nanjing 382
Boardman 256
Princeton 230
Lawrence 221
Helsinki 216
Los Angeles 194
Jacksonville 168
Medford 167
Wilmington 165
Nanchang 157
Shanghai 111
New York 110
Munich 107
Jiaxing 105
Changsha 99
Hangzhou 95
Shenyang 92
Hebei 91
Redondo Beach 84
Moscow 83
Buffalo 82
Ann Arbor 64
Tianjin 57
Ho Chi Minh City 53
Chicago 40
Dearborn 39
Turku 39
Hanoi 38
Toronto 38
Norwalk 36
Pavia 36
Warsaw 34
Tokyo 32
Atlanta 31
The Dalles 31
São Paulo 30
Brooklyn 27
Chennai 25
Boston 24
Guangzhou 24
Johannesburg 24
Denver 23
Fairfield 23
London 21
Zhengzhou 21
San Francisco 20
Columbus 19
Mexico City 19
Woodbridge 19
Stockholm 18
Washington 18
Falkenstein 17
Redwood City 17
Jinan 16
Kunming 14
Phoenix 14
Seattle 14
Montreal 13
Piscataway 13
Poplar 13
Santa Clara 13
Ningbo 12
Brussels 11
Rio de Janeiro 11
Ankara 10
Belo Horizonte 10
Nuremberg 10
Orem 10
Porto Alegre 10
Vienna 10
Amsterdam 9
Da Nang 9
Des Moines 9
Houston 9
Manchester 9
Taizhou 9
Baku 8
Buenos Aires 7
Fortaleza 7
Milan 7
New Delhi 7
Asunción 6
Brno 6
Charlotte 6
Council Bluffs 6
Dhaka 6
Haiphong 6
Nairobi 6
Tashkent 6
Verona 6
Brasília 5
Campinas 5
Düsseldorf 5
Totale 9.195
Salva come PNG Salva come JPEG
Nome #
Alterata espressione dei canali del Ca2+ in cellule progenitrici endoteliali di pazienti affetti da carcinoma cellulare renale, mielofibrosi idiopatica e tumore della mammella 125
Allopurinol Mouthwashes In Methotrexate-induced Stomatitis 121
27P * Common gene signature expressed by breast and kidney cancers-derived endothelial colony forming cells 120
Renal cell carcinoma-induced immunosuppression: an immunophenotypic study of lymphocyte subpopulations and circulating dendritic cells. 115
Sunitinib in advanced metastatic non-clear cell renal cell carcinoma: a single institution retrospective study. 111
Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme 111
Analysis of TERRA expression in Head and Neck Tumors. 110
Case report: long-lasting response in a patient with metastatic renal cell cancer receiving antitumor cytotoxic T lymphocytes 109
[Eosinophilic infiltration of the gastrointestinal system: description of a clinical case simulating a lymphoproliferative process] 107
Tivantinib for second-line treatment of MET-high, advanced hepatocellular carcinoma (METIV-HCC): a final analysis of a phase 3, randomised, placebo-controlled study 107
Antiproliferative and cytokinetic effects of the specific Akt inhibitor perifosine on different solid tumor cell lines. 104
Analysis of TERRA expression in Head and Neck Tumors. 103
Lingual metastasis from renal cell carcinoma: a case report and literature review. 102
Orai1 and Transient Receptor Potential channels as novel molecular targets to impair tumor neovascularisation in renal cell carcinoma and other malignancies 102
Changes in circulating pro-angiogenic cytokines, other than VEGF, before progression to sunitinib therapy in advanced renal cell carcinoma patients. 101
[Hypokalemic rhabdomyolysis and thiazide diuretics. 3 clinical cases] 100
Circulating endothelial progenitor cells from patients with renal cell carcinoma display aberrant VEGF regulation, reduced apoptosis and altered ultrastructure 99
Acute Kidney Injury in Cancer Patients 98
Acute promyelocytic leukaemia (APL): chemotherapy or bone marrow transplantation? 95
Ultrastructural and functional differences between normal and tumor endothelial progenitor cells 94
Endoplasmic reticulum Ca2+ handling and apoptotic resistance in tumor-derived endothelial colony forming cells 94
Allopurinol mouthwashes in the treatment of 5-fluorouracil-induced stomatitis 93
Osteonecrosis of the Jaw in Patients with Metastatic Renal Cell Cancer Treated with Bisphosphonates and Targeted Agents: Results of an Italian Multicenter Study and Review of the Literature 92
Catheter seeding of hepatocellular carcinoma following placement of a total implantable access port system 91
Deficient natural killer cell NKp30-mediated function and altered NCR3 splice variants in hepatocellular carcinoma 88
Breast and renal cancer—Derived endothelial colony forming cells share a common gene signature 86
Amifostine (WR-2721, Ethyol(TM)) can protect human endothelial but not tumor cells from cisplatin-induced cytotoxicity 85
Predictive value of baseline serum vascular endothelial growth factor and neutrophil gelatinase-associated lipocalin in advanced kidney cancer patients receiving sunitinib 85
Autoimmunity in thrombotic thrombocytopenic purpura 84
Circulating interleukin-6 as a tumor marker for hepatocellular carcinoma. 84
Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas 83
Telomeric repeat-containing RNAs (TERRA) decrease in squamous cell carcinoma of the head and neck is associated with worsened clinical outcome 82
Phenotypic and functional characterization of endothelial progenitor cells isolated from peripheral blood of renal cell carcinoma patients 82
Store-operated Ca2+ entry is over-expressed in endothelial colony forming cells isolated from patients suffering of Renal Cellular Carcinoma. 82
5-methyltetrahydrofolate or 5-formyltetrahydrofolic acid to modulate 5-fluorouracil's cytotoxic activity in vivo. A phase II study in patients with advanced colon cancer 82
Sarcoidosis following beta-interferon therapy for multiple myeloma 82
Cytokinetic and pro-apoptotic effects induced by inhibition of Aurora Kinases: a novel strategy for malignant mesothelioma treatment. 81
Store-operated Ca2+ entry is over-expressed in endothelial colony forming cells isolated from tumoral patients; its role in cell proliferation and tubulogenesis 81
Should CARMENA Really Change our Attitude Towards Cytoreductive Nephrectomy in Metastatic Renal Cell Carcinoma? A Systematic Review and Meta-Analysis Evaluating Cytoreductive Nephrectomy in the Era of Targeted Therapy 81
Cisplatin, mitomycin-C, 5-fluorouracil and leucovorin combination chemotherapy (l-FCM) in locally advanced unresectable or metastatic gastric carcinoma: a phase-II study 81
[Current approaches to the first-line treatment of clear-cell renal cell carcinoma] 80
Tumor and circulating biomarkers in patients with second-line hepatocellular carcinoma from the randomized phase II study with tivantinib 80
Thrombotic Thrombocytopenic Purpura In Systemic Lupus-erythematosus 79
Ocular involvement in acute thrombotic thrombocytopenic purpura 78
Thrombotic thrombocytopenic purpura resistant to plasma-exchange: salvage treatment with high-dose IgG or vincristine. Italian Cooperative Group for TTP 77
Tivantinib, a new option for second-line treatment of advanced hepatocellular carcinoma? the experience of Italian centers 77
Impaired bone marrow hematopoietic progenitor cell function in rheumatoid arthritis patients candidated to autologous hematopoietic stem cell transplantation 77
Progression-free survival as primary endpoint in randomized clinical trials of targeted agents for advanced renal cell carcinoma. Correlation with overall survival, benchmarking and power analysis 77
Algorithms in the first-line treatment of metastatic clear cell renal cell carcinoma—analysis using diagnostic nodes 77
Concurrent intra-arterial carboplatin administration and radiation therapy for the tretment of advanced head and neck squamous cell carcinima: short term results. 76
Prospective, randomized trial of sequential interleukin-3 and granulocyte- or granulocyte-macrophage colony-stimulating factor after standard-dose chemotherapy in cancer patients 76
Treatment of thrombotic thrombocytopenic purpura with high-dose immunoglobulins. Results in 17 patients. Italian Cooperative Group for TTP 76
Intravenous prostacyclin (as epoprostenol) infusion in thrombotic thrombocytopenic purpura. Four case reports and review of the literature. Italian Cooperative Group for Thrombotic Thrombocytopenic Purpura 76
Is It Possible to Improve Prognostic Classification in Patients Affected by Metastatic Renal Cell Carcinoma With an Intermediate or Poor Prognosis? 76
Prognostic value of the neutrophil-to-lymphocyte ratio in the ARQ 197-215 second-line study for advanced hepatocellular carcinoma 75
Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy 75
Prognostic Value of 18 F-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated with Docetaxel 75
Cationic protein-rich supernatants of cultured eosinophils from IL-2-treated patients have no cytotoxic activity on human renal cell carcinoma and melanoma cells: A preliminary report 74
Addressing the expected survival benefit for clinical trial design in metastatic castration-resistant prostate cancer: Sensitivity analysis of randomized trials 74
Surgical Resection Does Not Improve Survival in Patients with Renal Metastases to the Pancreas in the Era of Tyrosine Kinase Inhibitors 74
Tumor biopsy and patient enrollment in clinical trials for advanced hepatocellular carcinoma 73
Dovitinib (CHIR258, TKI258): Structure, development and preclinical and clinical activity 72
Chronic myeloid leukemia following cyclophosphamide-containing chemotherapy in a breast cancer patient 72
Verapamil inhibits to different extents agonist-induced Ca2+ transients in human tumor cells and in vitro tumor cell growth 72
Vincristine sulfate for the treatment of thrombotic thrombocytopenic purpura refractory to plasma-exchange. The Italian Cooperative Group for TTP 72
A systematic review of sequencing and combinations of systemic therapy in metastatic renal cancer 72
Eosinophils and C4 predict clinical failure of combination imunotherapy with very low dose subcutaneous interleukin-2 and interferon in renal cell carcinoma patients 71
Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma 71
Targeted therapy for renal cell carcinoma: Focus on 2nd and 3rd line 71
Colon cancer in pregnancy: report of a case and review of the literature 70
Increased serum lipase with associated normoamylasemia in cancer patients 70
Hypocholesterolemia and acute myeloid leukemia (AML) 69
Store-operated Ca2+ entry is remodelled and controls in vitro angiogenesis in endothelial progenitor cells isolated from tumoral patients 69
Safety and efficacy of sunitinib in patients from Italy with metastatic renal cell carcinoma: Final results from an expanded-access trial 69
Editorial Comment from Dr Porta et al. to Patterns of care among patients receiving sequential targeted therapies for advanced renal cell carcinoma: A retrospective chart review in the USA 68
[Correlation between the grade of histological malignancy and nuclear positivity using the AgNOR technique in 6 cases of isolated bone NHL] 68
Clinical impact of Pancreatic metastases from renal cell carcinoma: A multicenter retrospective analysis 68
PD-1 blockade therapy in renal cell carcinoma: Current studies and future promises 68
Prognostic Role of PD-L1 Expression in Renal Cell Carcinoma. A Systematic Review and Meta-Analysis 68
Bone metastases in patients with metastatic renal cell carcinoma: Are they always associated with poor prognosis? 68
Renal effects of targeted anticancer therapies 67
Nitrite/nitrate balance during photoinduced cerebral ischemia in the rat determined by high-performance liquid chromatography with UV and electrochemical detection 67
Antiplatelet agents in thrombotic thrombocytopenic purpura (TTP). Results of a randomized multicenter trial by the Italian Cooperative Group for TTP 67
Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted Agents 67
Doxorubicin/methotrexate/fluorouracil in advanced pancreatic cancer 67
Retrospective analysis on safety and efficacy of everolimus in treatment of metastatic renal cancer patients receiving dialysis 67
Nephrectomy As A Component of Systemic Treatment For Renal-cell Carcinoma Patients 66
Rebuttal to: The usefulness of compression ultrasonography of the lower limbs in patients with a clinical suspicion of pulmonary embolism 66
Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: The RAINBOW analysis 66
Tivantinib (ARQ197) in hepatocellular carcinoma 66
Chronic Epstein-Barr virus infection 66
Platelet agonists and calcium homeostasis in endothelial cells: possible role in the interaction of endothelium with hemostatic system 66
Autoantibody Profile In Thrombotic Thrombocytopenic Purpura 65
Kidney transplantation in patients with previous renal cancer: a critical appraisal of current evidence and guidelines 65
5-Fluorouracil combined with the pure L-stereoisomer of leukovorin calcium to treat advanced colon-cancer patients - a phase-ii study 65
Intrapleural interleukin-2 induces nitric oxide production in pleural effusions from malignant mesothelioma: a possible mechanism of interleukin-2-mediated cytotoxicity? 65
Corrigendum to Sunitinib administered on 2/1 schedule in patients with metastatic renal cell carcinoma: The RAINBOW analysis [Ann Oncol 26, 2015 2107-2113] (doi: 10.1093/annonc/mdv315)] 65
The changes of lipid metabolism in advanced renal cell carcinoma patients treated with everolimus: A new pharmacodynamic marker? 65
The effect of a treatment delay on outcome in metastatic renal cell carcinoma 65
Intrahepatic fluorodeoxyuridine to treat unresectable hepatocellular carcinoma patients 64
Totale 8.080
Salva come PNG Salva come JPEG
Categoria #
all - tutte 73.993
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 73.993
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021240 0 0 0 0 0 35 11 96 14 41 29 14
2021/2022836 9 2 35 8 18 11 8 56 47 23 152 467
2022/20232.824 363 212 47 175 187 236 1 134 1.350 15 72 32
2023/20241.019 136 189 36 60 92 286 16 58 7 40 59 40
2024/20252.945 88 250 102 62 41 132 77 241 764 107 355 726
2025/20263.558 591 477 869 642 924 55 0 0 0 0 0 0
Totale 13.664